• Users Online: 165
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
REVIEW ARTICLE
Year : 2020  |  Volume : 8  |  Issue : 2  |  Page : 53-63

Recent changes in guidelines on programmatic management of drug resistant tuberculosis in India 2019: a paradigm shift in tuberculosis control


Professor, Department of Respiratory Medicine, R.G. Kar Medical College, Kolkata, West Bengal, India

Correspondence Address:
Prof. (Dr.) Arunabha Datta Chaudhuri
Designation - Professor, Department of Respiratory Medicine R.G. Kar Medical College, Kolkata, Residence - BF-130, Sector - I, Salt Lake City, Kolkata - 700064
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jacp.jacp_47_20

Rights and Permissions

The new version of guidelines of programmatic management of drug resistant tuberculosis in India 2019 by Revised National Tuberculosis Control Programme, Central TB Division, Directorate General of Health Services, Ministry of Health & Family Welfare, Nirman Bhawan, New Delhi, integrates use of the shorter MDR TB regimen and all oral longer MDR TB regimen with new drugs under RNTCP with opportunity to modify the regimen based on DST results. There are mammoth and comprehensive changes in the guidelines on programmatic management of drug resistant tuberculosis in India 2019.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed206    
    Printed7    
    Emailed0    
    PDF Downloaded93    
    Comments [Add]    

Recommend this journal